期刊文献+

申克孢子丝菌体外药敏试验研究近况 被引量:4

在线阅读 下载PDF
导出
摘要 申克孢子丝菌是孢子丝菌病的致病菌,如何选择高效敏感的抗真菌药物对于有效治疗孢子丝菌病具有重要意义,抗真菌药物体外药敏试验是评价抗真菌药物抗真菌活性的重要手段。综述了申克孢子丝菌体外药敏试验的研究近况,展望了研究及应用前景。
出处 《中国真菌学杂志》 2009年第2期120-123,共4页 Chinese Journal of Mycology
基金 教育部科学技术研究重点项目(107002)
作者简介 王晓慧,女(汉族),博士,副主任医师.E-mail:liwu07@163.com 通讯作者:刘伟,E-mail:liuw90@yahoo.com
  • 相关文献

参考文献3

二级参考文献24

  • 1尤刚,于淞,谢珍珍,张美莲,李晓杰,柳曦光,关熙峰,杨发枝,柴力.伊曲康唑治疗孢子丝菌病的临床和实验室观察[J].中华皮肤科杂志,1996,29(5):360-361. 被引量:5
  • 2Wanger A,MiLLs K,Rex JH.Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for antiftmgal susceptibility testing:Enhanced abitity to detect amphotericin B resistant Candida Isolates.Antimicrob Agents Chemother 1995;39(11):2520-2522.
  • 3Colombo A,Barchiesi F,McGough DA,et al.Comparison of Etest and National Committee for Clinical laboratory Standards brothmacrodilution for azol antifungal susceptibility testing.J Clin Microbiol 1995;33(3):535-540.
  • 4Mcginnis MR,Nordoff N,Lif RK,et al.Sporothrix schenckii sensitivity to voriconazole,itraconazole and amphotericin B.Med Mycol 2001;39:369-371.
  • 5Sharkey M,Carol AK,Jonh RG,et al.Treatment of sporotrichosis with itraconazole.Am J Med 1993;95:279-285.
  • 6Ramirez J,Byrd RP Jr,Roy TM.Chronic cavitary pulmonary sporotrichosis:efficacy of oral itraconazole.J Ky Med Assoc 1998;96(3):103-105.
  • 7Sharkey-Mathis PK,Kauffman CA,Graybill JR,et al.Treatment of sporotrichosis with itraconazole.NIAID Mycoses Study Group.Am J Med 1993;95(3):279-285.
  • 8Winn RE,Anderson J,Piper J,et al.Systemic sporotrichosis treated with itraconazole.Clin Infect Dis 1993; 17(2):210-217.
  • 9Hay RJ.Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.Br J Dermatol 1999; 141(Suppl.56):36-40.
  • 10Pe'rez A.Terbinafine:broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.Mycoses 1999;42(Suppl.2):111-114.

共引文献22

同被引文献23

  • 1吕雪莲,刘晓明.孢子丝菌病的治疗进展[J].中国麻风皮肤病杂志,2006,22(7):585-588. 被引量:9
  • 2赵景辉,孙秋宁,闫岩,宿斌.申克孢子丝菌双相体外药物敏感试验研究[J].中国麻风皮肤病杂志,2007,23(7):575-578. 被引量:6
  • 3Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi [S]. Approved standard-Second edition M38-A2. CLSI, Wayne, PA ,2008.
  • 4Clinical and Laboratory Standards Institute. Reference method tor broth dilution antifungal susceptibility testing of yeasts [ S ]. Approved standard-Third edition M27-A3. CLSI, Wayne, PA ,2008.
  • 5Gutierrez-Galhardo MC, Zancope-Oliveira RM, Monz6n A, et al. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test [J]. Mycoses,2010,53 ( 3 ) :227-231.
  • 6Kohler LM, Hamdan JS, Ferrari TC. Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing [ J ]. Diagn Microbiol Infect Dis, 2007,58( 1 ) :117-120.
  • 7Kohler LM,Monteiro PC, Hahn RC,et al. In vitro susceptibilities of isolates of Sporithrix schenckii to itraconazole and terbinafine[J]. J Clin Microbiol,2004,42(9) :4319- 4320.
  • 8Silveira CP, Torres-Rodrlguez JM, Alvarado-Ramirez E, et al. MICs and minimum fungicidal concentrations of amphotericin B, itraeonazole, posaconazole and terbinafine in Sporothrix schenckii [J]. J Med Microbiol, 2009,58 ( Pt 12 ) : 1607-1610.
  • 9McGinnis MR, Nordoff N, Li RK, et al. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B[J]. Med Mycol, 2001,39(4) :369-371.
  • 10Ruiz-Cendoya M, Rodriguez MM, Marine M, et al. In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi[ J ]. Int J Antimicrob Agents,2008,32 (5) :418-420.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部